Spring Creek Capital’s Avanos Medical AVNS Stock Holding History

Spring Creek Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,322	Closed	-$763K	–	90
2018 Q2	$763K	Buy	+13,322	New	+$704K	0.09%	220

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Spring Creek Capital's AVNS Position: Q3 2018 in Review

Spring Creek Capital sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 13,322 shares — an estimated $763K sold.

Spring Creek Capital first reported a position in AVNS in Q2 2018 and held it in 1 quarter. The position peaked at $763K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

Spring Creek Capital reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 13,322 Avanos Medical shares in Q3 2018, an estimated $763K.
Spring Creek Capital first reported a position in Avanos Medical in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Avanos Medical position peaked at $763K in Q2 2018.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.